Brief CV:  Dr. Joaquín Dopazo, the director of the Computational Medicine Platform of the Progress and Health Foundation of the Andalusian Health System, and Academic of the Spanish Royal Academy of Medicine (RANM), boasts a long career of over 30 years as a data science researcher. He has held leadership positions directing computational biology departments in academic institutions (CNIO, CIPF) and companies (Glaxo Wellcome). Dr. Dopazo’s research has focused on the study of genomic and clinical data through systems biology and artificial intelligence. His goal is the application of medical data in personalized and precision medicine, and in drug discovery. With more than 350 articles published in international journals and an h-index of 70, Dr. Dopazo has participated in several national and international consortia and initiatives, such as the Medical Genome Project CIBERER, IMPaCT-data, ELIXIR, and 1+Million genomes, and belongs to various societies related to Artificial Intelligence, such as ELLIS or the Spanish Society of Artificial Intelligence in Biomedicine, of which he is a founding member, and the MAQC, where he served as president.